MFDS to Hold 'Pharmaceutical Approval Business Briefing' on the 24th
The Ministry of Food and Drug Safety announced on the 13th that it will hold the '2023 First Half Pharmaceutical Approval Work Briefing' on the 24th at the Korea Science and Technology Center in Gangnam-gu, Seoul, for pharmaceutical company personnel in charge of drug approval and reporting tasks.
At this briefing, information will be provided on this year's work plans and regulatory changes, the Common Technical Document (CTD) manufacturing methods for approval applications, reference drug applications, and considerations when applying for approval.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Those wishing to attend can apply in advance through the application website, and the presentation materials from the briefing will be released later on the MFDS website. The MFDS stated, "This briefing will help improve the industry's understanding of the pharmaceutical approval system," and added, "We will continue to actively organize opportunities for sharing and communication of approval-related information and operate the pharmaceutical approval and review system rationally based on proactive administration and regulatory science expertise."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
